Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial by Marco Maria Germani, Marco Maria Germani, Guglielmo Vetere, Guglielmo Vetere, Mirella Giordano, Mirella Giordano, Paolo Ciracì, Paolo Ciracì, Iolanda Capone, Elena Tamborini, Elena Conca, Adele Busico, Filippo Pietrantonio, Vittoria Matilde Piva, Vittoria Matilde Piva, Alessandra Boccaccino, Alessandra Boccaccino, Francesca Simionato, Martina Bortolot, Martina Bortolot, Paolo Manca, Sara Lonardi, Veronica Conca, Veronica Conca, Beatrice Borelli, Beatrice Borelli, Martina Carullo, Martina Carullo, Marzia Del Re, Gabriella Fontanini, Daniele Rossini, Daniele Rossini, Chiara Cremolini, Chiara Cremolini

Get full text

Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies by Valentina Fanotto, Daniele Rossini, Mariaelena Casagrande, Francesca Bergamo, Andrea Spagnoletti, Daniele Santini, Carlotta Antoniotti, Samanta Cupini, Francesca Daniel, Vincenzo Nasca, Guglielmo Vetere, Alberto Zaniboni, Beatrice Borelli, Martina Carullo, Veronica Conca, Alessandro Passardi, Emiliano Tamburini, Gianluca Masi, Nicoletta Pella, Chiara Cremolini

Get full text